We value your privacy

We use cookies to analyze site usage and improve your experience. You can accept all, reject non-essential, or customize. See our Privacy Policy.

HRT · Progestogens

Micronized progesterone vs synthetic progestins

Every woman with a uterus on estrogen needs a progestogen to protect the endometrium. But bioidentical micronized progesterone and synthetic progestins are chemically and clinically distinct. The distinction matters for breast, mood, and cardiovascular outcomes.

Written by the Kindr Health Editorial & Clinical TeamMedically reviewed by Kindr Health Clinical Team NPI 1609792902Published Last reviewed

Options for endometrial protection

  • Micronized progesterone 100–200mg oral at bedtime
  • Vaginal micronized progesterone (avoids sedation)
  • Levonorgestrel IUD (Mirena)
  • Synthetic progestins (MPA, norethindrone) — historical, largely superseded

Frequently asked questions

Are they interchangeable?

No. Micronized progesterone is molecularly identical to what the ovary makes; synthetic progestins are not.

Does progesterone cause breast cancer?

The E3N cohort found no increased breast cancer risk with estradiol + micronized progesterone for up to 5 years, unlike synthetic combinations.

Which is better for sleep?

Oral micronized progesterone at bedtime has mild sedative effects due to allopregnanolone metabolites.

Is a Mirena IUD acceptable?

Yes — off-label but widely used for endometrial protection with excellent local delivery and minimal systemic exposure.

Considering a physician-supervised longevity protocol? Kindr Health evaluates peptide therapy as part of personalized perimenopause and menopause care.

Request your Longevity Consult →

Explore Kindr Health

HRT Hub →
Estrogen, progesterone, testosterone protocols
34 Symptoms →
The complete symptom index
Care Near Me →
Find menopause care in your city
Browse by State →
Licensed clinicians in all 50 states
Kindr Journal →
Evidence-based menopause reporting
Editorial Team →
Who reviews Kindr clinical content

Related: FDA peptide review July 2026 briefing · Peptide therapy hub · Longevity service

Written and medically reviewed by the Kindr Health Clinical Team · Published 2026-06-19 · Last reviewed 2026-07-01. Compounded medications are prepared by FDA-registered 503A pharmacies and are not FDA-approved drug products.